Consumption of low dose fucoxanthin does not prevent hepatic and adipose inflammation and fibrosis in mouse models of diet-induced obesity

HIGHLIGHTS

• who: Mi-Bo Kim and colleagues from the Department of Nutritional Sciences, University of Connecticut, Storrs, CT, USA have published the article: Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity, in the Journal: Nutrients 2022, 14, 2280. of 12/03/2022
• what: The aim of this study was to examine whether FCX supplementation could attenuate obesity-associated metabolic abnormalities fibrosis and inflammation in two diet-induced obesity (DIO) mouse models. Using two different diets, the authors aimed to evaluate the potential preventive . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.